Real world COPD study may be better way to evaluate drug treatmentsBMJ 2016; 354 doi: https://doi.org/10.1136/bmj.i4796 (Published 05 September 2016) Cite this as: BMJ 2016;354:i4796
- Susan Mayor
A real world controlled effectiveness study carried out in unselected patients from UK general practices provides a better way of evaluating drug treatments for use in routine clinical care than standard randomised controlled trials, say the authors of a study in chronic obstructive pulmonary disease (COPD).1
The Salford Lung Study randomly assigned 2799 patients with COPD to a once daily inhaled combination of fluticasone-furoate and vilanterol or to usual care. The patients were recruited from 75 general practices in Salford …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial